These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 17114358
1. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays. Thomas RS, O'Connell TM, Pluta L, Wolfinger RD, Yang L, Page TJ. Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358 [Abstract] [Full Text] [Related]
2. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays. Thomas RS, Pluta L, Yang L, Halsey TA. Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802 [Abstract] [Full Text] [Related]
3. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Gaylor DW. Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536 [Abstract] [Full Text] [Related]
4. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver. Doktorova TY, Ellinger-Ziegelbauer H, Vinken M, Vanhaecke T, van Delft J, Kleinjans J, Ahr HJ, Rogiers V. Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513 [Abstract] [Full Text] [Related]
5. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Ellinger-Ziegelbauer H, Gmuender H, Bandenburg A, Ahr HJ. Mutat Res; 2008 Jan 01; 637(1-2):23-39. PubMed ID: 17689568 [Abstract] [Full Text] [Related]
6. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Kirkland D, Aardema M, Henderson L, Müller L. Mutat Res; 2005 Jul 04; 584(1-2):1-256. PubMed ID: 15979392 [Abstract] [Full Text] [Related]
7. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. Thomas RS, Clewell HJ, Allen BC, Wesselkamper SC, Wang NC, Lambert JC, Hess-Wilson JK, Zhao QJ, Andersen ME. Toxicol Sci; 2011 Mar 04; 120(1):194-205. PubMed ID: 21097997 [Abstract] [Full Text] [Related]
8. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ. Mutat Res; 2005 Aug 04; 575(1-2):61-84. PubMed ID: 15890375 [Abstract] [Full Text] [Related]
9. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis. Kim JY, Kwon J, Kim JE, Koh WS, Chung MK, Yoon S, Song CW, Lee M. Environ Mol Mutagen; 2005 Aug 04; 45(1):80-9. PubMed ID: 15612046 [Abstract] [Full Text] [Related]
10. Use of short-term transcriptional profiles to assess the long-term cancer-related safety of environmental and industrial chemicals. Thomas RS, Bao W, Chu TM, Bessarabova M, Nikolskaya T, Nikolsky Y, Andersen ME, Wolfinger RD. Toxicol Sci; 2009 Dec 04; 112(2):311-21. PubMed ID: 19776212 [Abstract] [Full Text] [Related]
11. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program. Natl Toxicol Program Tech Rep Ser; 2006 Jan 04; (520):4-246. PubMed ID: 16628245 [Abstract] [Full Text] [Related]
12. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens. Rohrbeck A, Salinas G, Maaser K, Linge J, Salovaara S, Corvi R, Borlak J. Toxicol Sci; 2010 Nov 04; 118(1):31-41. PubMed ID: 20713471 [Abstract] [Full Text] [Related]
13. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Nie AY, McMillian M, Parker JB, Leone A, Bryant S, Yieh L, Bittner A, Nelson J, Carmen A, Wan J, Lord PG. Mol Carcinog; 2006 Dec 04; 45(12):914-33. PubMed ID: 16921489 [Abstract] [Full Text] [Related]
14. The results of assays in Drosophila as indicators of exposure to carcinogens. Vogel EW, Graf U, Frei HJ, Nivard MM. IARC Sci Publ; 1999 Dec 04; (146):427-70. PubMed ID: 10353398 [Abstract] [Full Text] [Related]
15. Identification of tumor promotion marker genes for predicting tumor promoting potential of chemicals in BALB/c 3T3 cells. Maeshima H, Ohno K, Tanaka-Azuma Y, Nakano S, Yamada T. Toxicol In Vitro; 2009 Feb 04; 23(1):148-57. PubMed ID: 19000923 [Abstract] [Full Text] [Related]
16. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models. Jonker MJ, Bruning O, van Iterson M, Schaap MM, van der Hoeven TV, Vrieling H, Beems RB, de Vries A, van Steeg H, Breit TM, Luijten M. Carcinogenesis; 2009 Oct 04; 30(10):1805-12. PubMed ID: 19696161 [Abstract] [Full Text] [Related]
17. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods. Waters MD, Jackson M, Lea I. Mutat Res; 2010 Dec 04; 705(3):184-200. PubMed ID: 20399889 [Abstract] [Full Text] [Related]
18. Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N Rats and B6C3F1 Mice. National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1997 Sep 04; 460():1-414. PubMed ID: 12587016 [Abstract] [Full Text] [Related]
19. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Kirkland D, Aardema M, Müller L, Makoto H. Mutat Res; 2006 Sep 19; 608(1):29-42. PubMed ID: 16769241 [Abstract] [Full Text] [Related]
20. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing. Nioi P, Pardo ID, Sherratt PJ, Snyder RD. Chem Biol Interact; 2008 Apr 15; 172(3):206-15. PubMed ID: 18328469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]